New hope for men battling Tough-to-Treat prostate cancer
Disease control
Recruiting now
This study is testing a new injection called INR102 for men with advanced prostate cancer that has spread and stopped responding to standard hormone and chemotherapy treatments. The main goals are to see if the treatment is safe, how the body processes it, and if it can help redu…
Phase: PHASE1, PHASE2 • Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC